Ebenezer I.

Postdoctoral Fellow @Van Andel Institute

Grand Rapids, MI, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jul 2024 — Present

Postdoctoral Fellow @Van Andel Institute

View department →

Grand Rapids, MI, US

Develop gene therapy for neurodegenerative diseases using rodent and patient-derived iPSC models, while maintaining institutional regulatory and biosafety compliance.• Maintain regulatory and biosafety compliance in BSL-2 laboratories, including protocol documentation for institutional audits and adherence to NIH and VAI’s Institutional Animal Care and Use Committee (IACUC) standards.• Coordinate preparation and review of study protocols, amendments, and inspection documents for regulatory committees such as IACUC, supporting internal and external audits.• Liaise with institutional committees and facilities teams for regulatory audits and emergency preparedness, ensuring continuous compliance and safety. • Generated preliminary data supporting my successful institutional Pathway to Independence award to advance independent research development.

EDUCATION

2018 — 2020

Ulm University

Master of Science - MS, Molecular and Translational Neuroscience

2007 — 2011

University of Port Harcourt

Bachelor of Science (B.Sc.), Human Anatomy

N/A

Central Michigan University

Doctor of Philosophy - PhD, Neuroscience

2016 — 2017

University of Lagos

Master of Science - MS, Anatomy

ABOUT EBENEZER I.

Regulatory affairs professional with experience supporting U.S. Investigational New Drug Chemistry, Manufacturing, and Controls documentation and European Union variation submissions within the Common Technical Document framework. I work at the intersection of regulatory, manufacturing, and quality teams to coordinate CMC information, interpret evolving regulatory guidelines, and support compliant and timely submissions across U.S. and EU markets. My Ph.D. and postdoctoral training involved applying adeno-associated virus (AAV)-based gene therapy approaches in models of Huntington’s and Parkinson’s disease to evaluate therapeutic and functional outcomes. Interested in regulatory affairs roles supporting biologics, advanced therapies, and gene therapy programs.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.